Sage Therapeutics Seeks FDA Approval for Brexanolone in Postpartum Depression - AJMC.com Managed Markets NetworkGoogle NewsMon, April 23rd - 3:00 AM 2018
Sage Therapeutics: Analyzing New Product Candidates - Market RealistGoogle NewsTue, December 18th - 3:00 AM 2018
Why Sage Therapeutics Is Skyrocketing Today - Motley FoolGoogle NewsMon, January 7th - 3:00 AM 2019
A drug that works differently from all existing depression drugs just got a big boost - Business Insider - Business InsiderGoogle NewsSun, January 13th - 3:00 AM 2019
Here's Why Sage Therapeutics Gained 48.9% in January - The Motley FoolGoogle NewsSun, February 10th - 3:00 AM 2019
Sage Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress - Business WireGoogle NewsTue, February 19th - 3:00 AM 2019
FDA approves first postpartum depression drug - RADIO.COMGoogle NewsTue, March 19th - 3:00 AM 2019
Is Sage Therapeutics a Good Stock to Buy Now? - The Motley FoolGoogle NewsWed, March 20th - 3:00 AM 2019
FDA Approves Drug For Treating Postpartum Depression - RADIO.COMGoogle NewsWed, March 20th - 3:00 AM 2019
Shares of Sage Therapeutics up on Zulresso approval, but analysts expect a slow rollout - MarketWatchGoogle NewsThu, March 21st - 6:54 AM 2019

Pages